Journal of Oncology Pharmacy Practice

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, J. P.
Right arrow Articles by Jones, S. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Baker, J. P.
Right arrow Articles by Jones, S. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Oncology Pharmacy Practice, Vol. 4, No. 1, 10-14 (1998)
DOI: 10.1177/107815529800400101

Rationalisation of chemotherapy services in the University Hospital Birmingham National Health Science Trust

James P. Baker, MBA, MRPharmS

Oncology Services, Queen Elizabeth Hospital

Sarah E. Jones, BSc(Hons), MRPharmS

Pharmacy Department, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH

Objectives. To audit chemotherapy prescribing in out-patient clinics in order to develop a novel ap proach for the provision of chemotherapy services to peripheral clinics.

Method. Two audits of CMF (cyclophospha mide, methotrexate, and 5-fluorouracil) chemother apy were performed to initially determine the feasi bility and cost effectiveness of a centralised chemotherapy service. Subsequently, an audit was performed to develop a system for the rationalisation of chemotherapy prescribing using dose-banding.

Results. The results from the first audit showed that of the 97 courses of chemotherapy prescribed in the peripheral out-patient clinic, 13.5% were de ferred. All deferred chemotherapy was reissued amounting to a saving of £681.00 over the 6 months studied. The second audit compiled data from 380 courses of CMF and enabled a dose-banding system to be developed. A system was devised so that an agreed 5% variance from the dose prescribed enabled pre filled chemotherapy syringes to be supplied, with no more than two syringes being used per dose.

Conclusion. In conclusion, the prefilled syringe programme has improved patient waiting times, re duced drug wastage, and has enabled rationalisation of chemotherapy services in this health district.

Key Words: Chemotherapy services • audit • pharmacy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Oncol Pharm PractHome page
S. Kaestner and G. Sewell
Dose-banding of carboplatin: rationale and proposed banding scheme
Journal of Oncology Pharmacy Practice, June 1, 2007; 13(2): 109 - 117.
[Abstract] [PDF]


Home page
J Oncol Pharm PractHome page
S. Kaestner and G. Sewell
A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate `dose-banding'
Journal of Oncology Pharmacy Practice, June 1, 2007; 13(2): 119 - 126.
[Abstract] [PDF]